Transcranial Direct Current Stimulation to Reduce Chronic Pelvic Pain in Endometriosis
NCT ID: NCT05231239
Last Updated: 2022-02-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE2
40 participants
INTERVENTIONAL
2021-01-01
2023-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Hypothesis: Transcranial direct current stimulation can reduce the perception of pelvic pain in patients with patients with endometriosis.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
THE EFFECT OF tDCS IN THE TREATMENT OF CHRONIC PELVIC PAIN ASSOCIATED WITH ENDOMETRIOSIS
NCT02161302
Effect of Repetitive Transcranial Direct Current Stimulation (tDCS) on Chronic Pelvic Pain
NCT00554320
Transcranial Direct Stimulation in Chronic Pelvic Pain
NCT01143636
Physical Performance and Analgesic Effects of tDCS in Primary Dysmenorrhea
NCT03184740
Repetitive Transcranial Magnetic Stimulation as an Analgesic Treatment in Endometriosis Chronic Pain : Feasibility
NCT03204682
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Active tDCS
tDCS will be applied for 20 min with 2 mA
tDCS : Transcranial direct current stimulation
Transcranial direct current stimulation
Placebo tDCS
tDCS will be applied for only 20 sec, monatge will be left on the head for 20 min
tDCS : Transcranial direct current stimulation
Transcranial direct current stimulation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
tDCS : Transcranial direct current stimulation
Transcranial direct current stimulation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
50 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Charite University, Berlin, Germany
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Magdalena S. Prüß née Volz
Principal Investigator ; PD Dr. med.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Magdalena S Prüß, MD
Role: PRINCIPAL_INVESTIGATOR
Charite University Medicine Berlin, Germany, 12200
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Charite University Medicine
Berlin, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Mechsner S, Grunert J, Wiese JJ, Vormbaumen J, Sehouli J, Siegmund B, Neeb L, Pruss MS. Transcranial direct current stimulation to reduce chronic pelvic pain in endometriosis: phase II randomized controlled clinical trial. Pain Med. 2023 Jul 5;24(7):809-817. doi: 10.1093/pm/pnad031.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EA1/174/19
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.